January 6, 2026 · Form 4 insider transaction
WAGNER CHARLES F JR sold 9,532 shares of Vertex Pharmaceuticals Incorporated at $461.00 per share, a transaction worth $4.39M. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Transaction made pursuant to Mr. Wagner's company approved trading plan under Rule 10b5-1, which was entered into on 5/09/2025.